Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs

Selen F., TEKELİ O., YANIK ODABAŞ Ö.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, vol.33, no.3, pp.170-175, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.1089/jop.2016.0128
  • Journal Name: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.170-175
  • Keywords: central macular thickness, flare, glaucoma, macular edema, prostaglandins, BLOOD-AQUEOUS BARRIER, OPEN-ANGLE GLAUCOMA, LATANOPROST 0.005-PERCENT, INTRAOCULAR-PRESSURE, OCULAR HYPERTENSION, PROSTAGLANDIN ANALOGS, TIMOLOL MALEATE, EDEMA, UVEITIS, BIMATOPROST
  • Ankara University Affiliated: Yes

Abstract

Purpose: To determine the changes in the anterior chamber flare and central macular thickness (CMT) under topical antiglaucomatous therapy.